Tivorbex
Product Images NDC 42211-202

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tivorbex (NDC 42211-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Iroko Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Chemical Structure For Tivorbex (indomethacin) Capsule Is A Nonsteroidal Anti-inflammatory Drug, Available As Hard Gelatin Capsules Of 20 mg And 40 mg For Oral Administration. The Chemical Name Is 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetic Acid. The Molecular Weight Is 357.8. Its Molecular Formula Is C19h16clno4. (Tivorbex 01)

The Following Chemical Structure For Tivorbex (indomethacin) Capsule Is A Nonsteroidal Anti-inflammatory Drug, Available As Hard Gelatin Capsules Of 20 mg And 40 mg For Oral Administration. The Chemical Name Is 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetic Acid. The Molecular Weight Is 357.8. Its Molecular Formula Is C19h16clno4. (Tivorbex 01)
Chemical structure diagram of the active ingredient in Tivorbex by Iroko Pharmaceuticals, LLC. The diagram shows molecular bonds and atom groups including methoxy, methyl, chloro, and carboxyl groups arranged on fused aromatic rings and a nitrogen-containing heterocycle.*
FDA Label Image

Figure 1 Average Pain Intensity Over 48 Hours For Tivorbex And Placebo Groups – Study 1 (Tivorbex 02)

Figure 1 	Average Pain Intensity Over 48 Hours For Tivorbex And Placebo Groups – Study 1 (Tivorbex 02)
A line graph comparing mean VAS pain intensity scores over 48 hours for Tivorbex Capsules at 40 mg TID, 40 mg BID, 20 mg TID, and placebo. The x-axis represents time in hours, and the y-axis shows pain intensity scores, indicating pain reduction trends for each treatment group.*
FDA Label Image

Figure 2 Average Pain Intensity Over 48 Hours For Tivorbex And Placebo Groups – Study 2 (Tivorbex 03)

Figure 2 	Average Pain Intensity Over 48 Hours For Tivorbex And Placebo Groups – Study 2 (Tivorbex 03)
A line graph comparing mean VAS pain intensity scores over 48 hours for Tivorbex capsules at various dosages (40 mg TID, 40 mg BID, 20 mg TID) and placebo. The x-axis represents time in hours, and the y-axis represents pain intensity scores. Multiple lines track the pain reduction trends for each group.*
FDA Label Image

Principal Display Panelndc 42211-201-29tivorbex(indomethacin) Capsules20 mgper Capsule90 Capsulesrx Only (Tivorbex 04)

Principal Display Panelndc 42211-201-29tivorbex(indomethacin) Capsules20 mgper Capsule90 Capsulesrx Only (Tivorbex 04)
Label for Tivorbex (indomethacin) capsules, showing strength of 20 mg per capsule. The label includes an image of a blue capsule marked with "20 mg" and "IP-201." It indicates a supply of 90 capsules, prescription only, and is distributed by Iroko Pharmaceuticals, LLC. Storage instructions and a barcode are also present.*
FDA Label Image

Principal Display Panelndc 42211-202-29tivorbex(indomethacin) Capsules40 mgper Capsule90 Capsulesrx Only (Tivorbex 05)

Principal Display Panelndc 42211-202-29tivorbex(indomethacin) Capsules40 mgper Capsule90 Capsulesrx Only (Tivorbex 05)
Tivorbex (indomethacin) capsules 40 mg label showing dosage strength per capsule, with a blue and teal capsule image marked '40 mg' and 'IP-202'. The label states Rx Only, contains 90 capsules, and is distributed by Iroko Pharmaceuticals, LLC. Includes storage instructions, a barcode, lot and expiration fields, and a warning to dispense the accompanying medication guide to each patient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.